Insider Transactions in Q3 2022 at Zynerba Pharmaceuticals, Inc. (ZYNE)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 19
2022
|
Terri B Sebree President |
SELL
Open market or private sale
|
Direct |
8,281
-2.2%
|
$8,281
$1.1 P/Share
|
|
Jul 19
2022
|
Brian Rosenberger VP, Commercial & Business Dev. |
SELL
Open market or private sale
|
Direct |
4,289
-3.84%
|
$4,289
$1.1 P/Share
|
|
Jul 19
2022
|
James E Fickenscher Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,013
-3.37%
|
$6,013
$1.1 P/Share
|
|
Jul 19
2022
|
Armando Anido Chairman & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
11,899
-1.91%
|
$11,899
$1.1 P/Share
|
|
Jul 18
2022
|
Terri B Sebree President |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+7.39%
|
-
|
|
Jul 18
2022
|
Brian Rosenberger VP, Commercial & Business Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
14,800
+11.69%
|
-
|
|
Jul 18
2022
|
James E Fickenscher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,800
+10.44%
|
-
|
|
Jul 18
2022
|
Armando Anido Chairman & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,164
+6.47%
|
-
|